nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
C3 and alternative pathway components are associated with an adverse lipoprotein subclass profile: The CODAM study
|
Xin, Ying |
|
|
15 |
2 |
p. 311-319 |
artikel |
2 |
Case report: 68 yo Chinese-American woman with high HDL-C and ischemic stroke attributed to intracranial atherosclerotic stenosis
|
Gong, Jan |
|
|
15 |
2 |
p. 248-254 |
artikel |
3 |
Characteristics and trends of PCSK9 inhibitor prescription fills in the United States
|
Attipoe-Dorcoo, Sharon |
|
|
15 |
2 |
p. 332-338 |
artikel |
4 |
Closing the gap: Identification and management of familial hypercholesterolemia in an integrated healthcare delivery system
|
Birnbaum, Richard A. |
|
|
15 |
2 |
p. 347-357 |
artikel |
5 |
Collateral damage of the COVID-19 pandemic on the management of homozygous familial hypercholesterolemia
|
Kayikcioglu, Meral |
|
|
15 |
2 |
p. 381-382 |
artikel |
6 |
Editorial Board
|
|
|
|
15 |
2 |
p. A1-A4 |
artikel |
7 |
Effect of bariatric surgery on plasma levels of oxidised phospholipids, biomarkers of oxidised LDL and lipoprotein(a)
|
Ho, Jan Hoong |
|
|
15 |
2 |
p. 320-331 |
artikel |
8 |
From the editor: Competition and community
|
Guyton, John R. |
|
|
15 |
2 |
p. 243 |
artikel |
9 |
Interrogation of selected genes influencing serum LDL-Cholesterol levels in patients with well characterized NAFLD
|
Vilar-Gomez, Eduardo |
|
|
15 |
2 |
p. 275-291 |
artikel |
10 |
Long term follow-up of children with familial hypercholesterolemia and relatively normal LDL-cholesterol at diagnosis
|
Johansen, Anja K. |
|
|
15 |
2 |
p. 375-378 |
artikel |
11 |
News from the NLA
|
|
|
|
15 |
2 |
p. 244 |
artikel |
12 |
Nut consumption, risk of cardiovascular mortality, and potential mediating mechanisms: The Women's Health Study
|
Imran, Tasnim F. |
|
|
15 |
2 |
p. 266-274 |
artikel |
13 |
Phenotypic characterization and predictive analysis of p.Asp47Asn LDL receptor mutation associated with Familial Hypercholesterolemia in a Chilean population
|
Sánchez, Andrea |
|
|
15 |
2 |
p. 366-374.e1 |
artikel |
14 |
Prevention: The past, present, and future of medicine and society
|
Agarwala, Anandita |
|
|
15 |
2 |
p. 245-247 |
artikel |
15 |
Prognostic impact of cascade screening for familial hypercholesterolemia on cardiovascular events
|
Tada, Hayato |
|
|
15 |
2 |
p. 358-365 |
artikel |
16 |
Proprotein convertase subtilisin/kexin type 9 inhibitor utilization and low-density lipoprotein-cholesterol control in familial hypercholesterolemia
|
Jackson, Candace L. |
|
|
15 |
2 |
p. 339-346 |
artikel |
17 |
Table of Contents
|
|
|
|
15 |
2 |
p. A5-A6 |
artikel |
18 |
The impact of dyslipidemia on early markers of endothelial and renal dysfunction in children
|
Kosmeri, Chrysoula |
|
|
15 |
2 |
p. 292-300 |
artikel |
19 |
The triglyceride to HDL-cholesterol ratio and chronic graft failure in renal transplantation
|
Anderson, Josephine L.C. |
|
|
15 |
2 |
p. 301-310 |
artikel |
20 |
Utility of metabolic syndrome as a risk enhancing factor in decision of statin use
|
Vega, Gloria Lena |
|
|
15 |
2 |
p. 255-265 |
artikel |
21 |
Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19
|
Vuorio, Alpo |
|
|
15 |
2 |
p. 379-380 |
artikel |